Delivery Order SPE2DB24D2205-SPE2DB25FEFQD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,624.36 for TREMFYA 100 mg/mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a monoclonal antibody used to treat moderate to severe plaque psoriasis and other...
- The Defense Logistics Agency awarded a $14,539.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL syringes. This order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat psoriasis and psoriatic arthritis, indicating this delivery supports...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $19,006 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical products on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a $16,533.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML syringes and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and...
- This is a $12,274.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TREMFYA 100 MG/ML ONE-PRESS syringes, with a period of performance through July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $54,949.91, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of November 1, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 30, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFQDDelivery Order
The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the prime vehicle for global pharmaceutical supply to military and federal healthcare systems. TREMFYA (guselkumab) is a specialty pharmaceutical product used for the treatment of psoriasis and other immune-mediated inflammatory conditions. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling specialized medication requirements for the Defense Health Agency and other military healthcare programs. The company's comprehensive IDC vehicle enables flexible procurement of pharmaceuticals, vaccines, medical devices, and related supplies across multiple therapeutic domains in support of military readiness and veteran care initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.7k | 7/30/25 |